Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 26, 2025
Alcohol, cannabis use after cancer: ‘eye-opening’ prevalence
Fred Hutch researchers surprised after digging into patients’ use of substances after diagnosis
Examining the role of financial worry in cancer survivorship
From the Jones and Newcomb Labs, Public Health Sciences Division
Some laxatives may be more colon-friendly than others
From the Newcomb Group, Public Health Sciences Division
Science to watch in 2018: From immunotherapy to gene therapy, big data to new tech
Fred Hutch experts lend their predictions for the coming year’s advances
10 highlights of Fred Hutch science in 2017
A look back at notable discoveries in cancer immunotherapy, HIV prevention and more
Good News: Dr. Gary Gilliland speaks to members of Congress about federal research funding
Celebrating faculty and staff achievements
Aspirin and its cousins linked to longer survival after colorectal cancer
Large study of preventive drugs for colorectal cancer survivors finds link to decreased mortality — but only for those with certain tumor genetics
Fred Hutch medical tipsheet for July
Cancer moonshot, research, global health, HIV vaccine, health care policy story ideas and more
Good News at Fred Hutch
Celebrating faculty and staff achievements
Good News at Fred Hutch
Public health researchers get $4 million grant to study aggressive type of colorectal cancer; Core Center of Hematology designated as national core resource
When diseases collide: Less than half of cancer survivors have been tested for HIV
Not knowing HIV status can affect treatment and prognosis of two debilitating conditions, finds CDC study of adults younger than 65
NCI awards $7.5 million for new cancer screening statistical coordination center
Public Health Sciences Division’s Ziding Feng, Bill Barlow co-lead nationwide PROSPR program to reduce deaths, health care costs for breast, colon, cervical cancers